Clinical trial
A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed…
NCT00078000 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00078000 |
|---|---|
| Title | A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies. |
| Official title | A Phase 2 Study Of The Efficacy And Safety Of SU011248 In Patients With Metastatic Breast Cancer |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Drug |
| Interventions | SU011248 |
| Enrollment | 64 |
| Start date | Mar 1, 2004 |
| Completion | Nov 1, 2005 |
| First posted | Feb 18, 2004 |
| Last update posted | Nov 26, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: